Avastin®, a cancer drug, has been shown to increase patient death from adverse events when used in conjunction with chemotherapy or biological therapy, according to new analysis of previous studies.

By transforming themselves into blood-vessel cells, brain-cancer cells have the ability to defy drugs that attempt to cut off blood in order to starve a brain tumor.

Blocking a rogue gene known as WWP2 has led scientists at the University of East Anglia to better understanding of how cancer spreads -- and how to stop it.

Researchers have revealed how a genetic mutation closely linked to some brain cancers and leukemia may contribute to cancer development.

An enzyme known as chondroitinase might help oncolytic viruses (cancer-fighting viruses) more effectively destroy cancer cells in brain tumors by clearing out protein molecules that deter the virus’s mission.